This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krause, P. J.
Right arrow Articles by Bakken, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krause, P. J.
Right arrow Articles by Bakken, J. S.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Ehrlichia and Anaplasma Infections...
PEDIATRICS Vol. 112 No. 3 September 2003, pp. e252-e253

ELECTRONIC ARTICLE

Successful Treatment of Human Granulocytic Ehrlichiosis in Children Using Rifampin

Peter J. Krause, MD*, Cathy L. Corrow, MD* and Johan S. Bakken, MD{ddagger}

* Department of Pediatrics, University of Connecticut School of Medicine and Connecticut Children’s Medical Center, Hartford, Connecticut
{ddagger} Section of Infectious Diseases, St Mary’s/Duluth Clinic Health System, Duluth, Minnesota

Human granulocytic ehrlichiosis (HGE) is an emerging tick-borne infectious disease caused by Anaplasma phagocytophilum. Clinical features include a flu-like illness that usually resolves within 1 week. More serious infection may occur that requires hospital admission or culminates in death. Doxycycline is the treatment of choice for HGE but may cause permanent staining of teeth in children younger than 8 years of age. We report successful treatment of HGE with rifampin in 2 children, 4 and 6 years old. A course of rifampin for 5 to 7 days should be considered in children younger than 8 years of age who experience non-life-threatening A phagocytophilum infection.

Key Words: human granulocytic ehrlichiosis • HGE • A phagocytophilum • rifampin

Abbreviations: HGE, human granulocytic ehrlichiosis • WBC, white blood cell count

Received for publication Feb 13, 2003; Accepted May 15, 2003.




This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
S. J. Swanson, D. Neitzel, K. D. Reed, and E. A. Belongia
Coinfections Acquired from Ixodes Ticks
Clin. Microbiol. Rev., October 1, 2006; 19(4): 708 - 727.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Branger, J. M. Rolain, and D. Raoult
Evaluation of Antibiotic Susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by Real-Time PCR
Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4822 - 4828.
[Abstract] [Full Text] [PDF]